Long-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry
Recruiting · NCT06075628 · Observational (researchers observe without assigning treatment) · Lead sponsor: Kansas City Heart Rhythm Research Foundation
View the official record on ClinicalTrials.gov →Interventions studied
Left Atrial Appendage Occlusion
What this trial is about
This study is intended to assess the incidence and correlation to the development of peri-device leaks (PDLs), device related thrombosis (DRTs) and cerebral vascular accident (CVA)/transient ischemic attacks (TIAs) in association with left atrial appendage contrast flow (LAA-CF). It will be a multi-center, retrospective study. Approximately 100 subject charts will be reviewed.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Subjects must be at least 18 years of age.
- Subjects underwent LAA closure with Watchman/Watchman FLX or Amplatzer Amulet at our institution from January 2019 till June 2022
Exclusion criteria
- No definite exclusion criteria are defined for the study as all patients with Watchman-FLX or Amplatzer Amulet will be included in the study.
Where it is running
1 location listed across 1 US state.
- Kansas City Heart Rhythm Institute - Overland Park, Kansas, United States